Yu, M., Yamashita, M., Takada, M., Takabatake, D., Takahashi, M., Kochi, M., Uno, M., Kondo, M., Nagashima, T., Fujimoto, H., Sakakibara, J., Teranaka, R., Aogi, K., Otsuka, M. (2026). Clinical benefit of palbociclib retreatment after abemaciclib exposure in hormone receptor positive, HER2 negative metastatic breast cancer. Scientific Reports. https://doi.org/10.1038/s41598-026-58952-7